At their meeting on January 20, 2017, the Board of Directors of Deinove SA appointed Dr. Charles Woler, Bernard Fanget, Prof. Vincent Jarlier and Dr. Yannick Plétan following the resignation of Paul-Joël Derian, Dennis McGrew, Rodney Rothstein, and Nabil Sakkab. The four nominations will be submitted for ratification by the Annual General Meeting of May 16, 2017. A proposal from Philippe Pouletty, Charles Woler was appointed as the new Chairman of the Board while Philippe Pouletty, Michael Carlos and Christian Pierret remain members of the Board. Charles has the international experience and energy for effective chairmanship of the new Board. Charles Woler was formerly Chairman and CEO of Roche France, President and CEO of Cadus Pharmaceutical in the United States, Chairman of Smithkline Beecham Europe and General Manager of Bouchara Group, before heading the company Neuro3d.